Neuromuscular Blocking Agent Use in Acute Respiratory Distress Syndrome: Which Variable is Important?

Farshid Rahimibashar; Mahmood Salesi; Amir Vahedian-Azimi; Masoum Khosh Fetrat

Volume 6, Issue 3 , September 2021, , Pages 116-122

http://dx.doi.org/10.34172/hpr.2021.22

Abstract
  Background: The study of neuromuscular blocking agents (NMBAs) in the management of acute respiratory distress syndrome (ARDS) has provided conflicting results in terms of their effect on mortality.Objectives: The main purpose of this study was to evaluate mortality in ARDS patients who underwent NMBA.Methods: ...  Read More

Comparison of Fentanyl and Midazolam for the Sedation of Infants Under Mechanical Ventilation; A Randomized Clinical Trial

Bita Najafian; Bahareh Esmaeili; Mohammad Hossein Khosravi

Volume 2, Issue 3 , September 2017, , Pages 63-67

http://dx.doi.org/10.15171/hpr.2017.17

Abstract
  Background: Neonatal respiratory distress syndrome (NRDS), a life-threatening pulmonary disorder, involves 1% of all deliveries worldwide. Shallow breathing causes restlessness in infants, which itself affects pulmonary function; thus, sedative medications are used to preserve better pulmonary function. ...  Read More